230 related articles for article (PubMed ID: 5051107)
21. [Gout and hyperuricemia during fasting. Action of associated thyroid hormone therapy].
Asch L
Rev Rhum Mal Osteoartic; 1973 Jan; 40(1):27-30. PubMed ID: 4694305
[No Abstract] [Full Text] [Related]
22. [Treatment of gout and of certain rheumatisms with hyperuricemia caused by benziodarone].
Gerbaux JO; Rodhain J
Rev Rhum Mal Osteoartic; 1968 Mar; 35(3):98-115. PubMed ID: 5302427
[No Abstract] [Full Text] [Related]
23. [A new medicine for gout ailments: benziodarone].
Deshayes P; Cardinael Y
Rhumatologie; 1967; 19(7):255-8. PubMed ID: 5619724
[No Abstract] [Full Text] [Related]
24. [Gout and benziodarone].
Thomas J
Rein Foie; 1967; 10():249-60. PubMed ID: 6081452
[No Abstract] [Full Text] [Related]
25. Pathogenesis and clinical management of hyperuricemia and gout.
Mangini RJ
J Maine Med Assoc; 1979 Mar; 70(3):118-20, 122-7. PubMed ID: 374661
[No Abstract] [Full Text] [Related]
26. [Study of the hypouricemic effect of benziodarone in chronic renal insufficiency].
Ponticelli C; Locatelli F; Graziani G
Arch Ital Urol Nefrol; 1967; 40(6):461-75. PubMed ID: 5607121
[No Abstract] [Full Text] [Related]
27. [Pathogenesis and treatment of fast-induced hyperuricemia using benzbromarone].
Schräpler P; Schulz E
Med Welt; 1976 Mar; 27(12):575-81. PubMed ID: 1263801
[No Abstract] [Full Text] [Related]
28. [The hypouricemic effect of benziodarone].
Gospodinoff L; Salvini S
Clin Ter; 1969 Oct; 51(2):153-8. PubMed ID: 5365825
[No Abstract] [Full Text] [Related]
29. [Benziodarone in hyperuricemia due to renal insufficiency].
Boine L
Minerva Med; 1973 Jan; 64(4):157-9. PubMed ID: 4568713
[No Abstract] [Full Text] [Related]
30. [Benziodarone in the treatment of hyperuricemia].
Ravera M
Clin Ter; 1970 Mar; 52(5):407-16. PubMed ID: 5421984
[No Abstract] [Full Text] [Related]
31. [Uninterrupted therapy of hyperuricemia and gout].
Schilling F
Reumatizam; 1971; 18(3):79-82. PubMed ID: 5097291
[No Abstract] [Full Text] [Related]
32. [When and how to treat hyperuricemia].
Rubens-Duval A
Therapeutique; 1973 Apr; 49(4):263-5. PubMed ID: 4775219
[No Abstract] [Full Text] [Related]
33. [Uricosuric and anti-gout action of certain benzofuran derivatives].
Delbarre F; Auscher C; Amor B
Presse Med (1893); 1965 Nov; 73(48):2725-6. PubMed ID: 5842108
[No Abstract] [Full Text] [Related]
34. [A new uricemia-lowering agent: benziodarone. Its use in therapy of urate retention in the course of chronic renal insufficiency].
Bossini A; De Martino Rosaroll G
Policlinico Prat; 1969 Jul; 76(30):961-73. PubMed ID: 5402682
[No Abstract] [Full Text] [Related]
35. [Evaluation and treatment of hyperuricemia].
Wolfram G
Med Welt; 1973 Dec; 24(50):1969-73. PubMed ID: 4776217
[No Abstract] [Full Text] [Related]
36. [Effects of benziodarone on hyperuricemia].
Josef H; Cossermelli W; Debes AC; Kopersztych S
AMB Rev Assoc Med Bras; 1969 Sep; 15(9):381-2. PubMed ID: 5309746
[No Abstract] [Full Text] [Related]
37. [Gout and myxedema].
Ryckewaert A; Massé C; Jurmand SH; Caroit M; Durieu J; Guérin C; de Séze S
Sem Hop; 1967 Nov; 43(49):3059-62. PubMed ID: 4298290
[No Abstract] [Full Text] [Related]
38. [Drug therapy of hyperuricemia].
Gröbner W
Verh Dtsch Ges Inn Med; 1986; 92():492-7. PubMed ID: 3811551
[No Abstract] [Full Text] [Related]
39. Uricosuric effect of irtemazole in hyperuricemic patients without and with renal insufficiency.
Kamilli I; Gresser U; Pellkofer T; Löffler W; Zöllner N
Z Rheumatol; 1989; 48(6):307-12. PubMed ID: 2623976
[TBL] [Abstract][Full Text] [Related]
40. [Advances in drugs used to normalize hyperuricemia].
Tofuku Y; Hirata M
Nihon Rinsho; 1991 May; 49(5):1081-5. PubMed ID: 2067098
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
